A detailed history of Frazier Financial Advisors, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 498 shares of EXAS stock, worth $28,625. This represents 0.03% of its overall portfolio holdings.

Number of Shares
498
Previous 1,369 63.62%
Holding current value
$28,625
Previous $57.8 Million 41.32%
% of portfolio
0.03%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$42.43 - $70.83 $36,956 - $61,692
-871 Reduced 63.62%
498 $33.9 Million
Q2 2024

Aug 12, 2024

BUY
$41.33 - $74.26 $1,818 - $3,267
44 Added 3.32%
1,369 $57.8 Million
Q1 2024

May 13, 2024

BUY
$56.27 - $73.77 $59,871 - $78,491
1,064 Added 407.66%
1,325 $91.5 Million
Q4 2023

Feb 09, 2024

BUY
$59.06 - $75.72 $15,414 - $19,762
261 New
261 $19.3 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.